Published By : Prameya News Bureau | July 04, 2020 IST
Share
Brussels, July 4: The European Commission has authorised anti-viral drug remdesivir for the treatment against coronavirus on Friday, making it the first drug authorized at the European Union level for the treatment of Covid-19. "Today, the European Commission granted a conditional marketing authorization for the medicine remdesivir," the European Commission said in a press release, Xinhua reported. Stella Kyriakides, Commissioner for Health and Food Safety, said: "Today's authorisation of a first medicine to treat Covid-19 is an important step forward in the fight against this virus... We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus." The EU expedited the authorization, approving the drug in an exceptionally short timeframe, but not before the news that the US has already locked down a large supply of remdesivir, made by Gilead Sciences, in the coming months. The US Department of Health and Human Services confirmed Monday that it had secured all of the Gilead's production for July and 90 per cent of that for August and September for US hospitals, raising concerns in Europe. A spokesman for the European Commission told a press conference on Thursday that Brussels heard of the US move from media reports, meaning Washington didn't bother to inform its allies beforehand. The EU was in ongoing talks with Gilead Sciences to reserve a "sufficient number of doses", reporters were told. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
India marks 4th anniversary of first Covid-19 lockdown
Religious people coped better with Covid pandemic: Study
Covid infection no longer perceived as serious health problem: Study
Mankind Pharma donated Rs 250 cr for Covid relief due to miscalculation
Covid scare: 573 fresh cases in India, two deaths
Health Dept urges people to avoid crowd during New Year celebration
Mushroom derived bioactive compounds have potential to combat COVID-19, viral infections
Delhi Health Minister assesses Covid preparedness amid rising JN.1 variant cases across country
JN.1 variant dominates US with 50% of Covid cases: CDC
No real need for booster vaccination, say experts as JN.1 spreads in India
5 active COVID cases detected in Odisha
Mild earthquake jolts Chhattisgarh, no casualty reported
Fresh Covid cases cross 100-mark in K'taka; positivity rate 5.93%
JN.1 scare: Odisha Health Dept advises elderly people to use facemasks
Spike in Covid cases, 1 death reported in Karnataka
Karnataka reports 20 new Covid-19 cases, 2 deaths
Health Ministry issues advisory on continued Covid vigilance
WHO calls for raising surveillance amid global rise in Covid cases
Drugs to reverse brain ageing caused by Covid
Covid-19 heightens risk of heart attack, stroke: Research